Frank Baldino

DR. FRANK BALDINO JR., Ph.D., is Chairman, CEO and Founder of Cephalon,
Inc., an international biopharmaceutical company focused on the
development of novel compounds to treat sleep disorders, neurological
disorders and cancer. Dr. Baldino’s scientific expertise and vision has
led Cephalon to become one of the industry’s leading biopharmaceutical
organizations. During his career, Dr. Baldino has received numerous
honors and awards for his outstanding achievements in neuroscience and
business, including the Entrepreneur of the Year Awards from both the
Delaware Valley Venture Capital Association (1989) and Ernst & Young
(1991), and the Eastern Technology Council of Greater Philadelphia’s
Enterprise Award for Outstanding CEO Under 40 (1993) and CEO of the Year
(1996). Dr. Baldino has more than 16 years of scientific experience in
neurobiology, molecular biology and electrophysiology, and has authored
more than 100 publications in peer-reviewed journals such as Nature,
Journal of Neuroscience Research and Brain Research. He received his PhD
from Temple University in 1979 and held post-doctorate positions at the
University of Pennsylvania and UMDNJ – Rutgers Medical School. He also
holds adjunct academic appointments at Temple University and Allegheny
University Hospital in Philadelphia. From 1981 to 1987, Dr. Baldino
served as Senior Research Biologist in the medical products department
at E.I. DuPont de Nemours & Company, where he was responsible for
developing research strategies for identifying novel neuropharmaceutical
agents. Dr. Baldino currently serves on the boards of ViroPharma, Inc.,
Pharmacopeia, Inc., Adolor Corporation, Biotechnology Industry
Organization, and The Jackson Laboratory. He serves on the advisory
boards of the Benjamin Franklin Barrow Awards, National Venture Capital
Association, American Entrepreneurs for Economic Growth, Eastern
Technology Council of Greater Philadelphia and Technology Leaders LP.
Dr. Baldino is also a member of the visiting committees for the
University of Pennsylvania and Muhlenberg College.